{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/303897837"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "The present method will enable the researcher to distinguish whether the adverse drug event is due to; the patient taking too much drug, drug interactions, genomic, proteomic, phenotypic, or other factors unrelated to the drug per se. [0317] It is a further object of the present invention that by analyzing the patient monitoring, genomic, proteomic, and physiologic data, one will be able to predic" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "google.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/271228869"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/303897837" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/144006066"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/303897837"] } } }
